[Management of childhood idiopathic thrombocytopenic purpura: a survey of members of the French Society of Pediatric Hematology and Immunology (SHIP)].

P. Lutz, F. Villega, S. Ducassou, N. Entz-Werle, G. Michel
Archives de Pédiatrie. 2007-05-01; 14(5): 444-449
DOI: 10.1016/j.arcped.2006.12.005

Read on PubMed

AIM OF THE STUDY: The purpose of this study was to report in acute childhood
idiopathic thrombocytopenic purpura (ITP) the current practices of French
paediatric hematologists and to compare them to recent publications of American
and British teams.
METHOD: A questionnaire was sent online to the members of the French Society of
Pediatric Hematology/Immunology (SHIP). This questionnaire, adapted from a
similar american study conducted in 2001, asked 16 questions based on the
clinical presentation of a 5-year-old boy referred for an acute ITP.
RESULTS: 59/123 SHIP members responded to the survey. In response to question
regarding initial treatment, 86% of physicians would be given active treatments
and only 9% would rarely or never administer any drug. When asked which agent
would be used in case of treatment, 68% would choose to prescribe intravenous
immunoglobulins and 32% corticosteroids, nobody recommended the use of anti-D
immunoglobulins. Furthermore, 83% would usually hospitalize such a child.
CONCLUSION: Finally, this study allowed us to update the current French
management of treating pediatric ITP which is almost comparable among this subset
of pediatric hematologists, but showed some discrepancies comparatively to the
American and British studies.

Know more about